We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+21.57%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$734M
AUM Growth
+$11.9M
Cap. Flow
-$87.4M
Cap. Flow %
-11.9%
Top 10 Hldgs %
32.05%
Holding
98
New
33
Increased
14
Reduced
20
Closed
29

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$24.8M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$20.6M
3
SNY icon
Sanofi
SNY
+$19.6M
4
WBA
Walgreens Boots Alliance
WBA
+$19M
5
TFX icon
Teleflex
TFX
+$15M

Top Sells

Rank Stock Value
1
ARGX icon
argenx
ARGX
+$34.4M
2
MCK icon
McKesson
MCK
+$21.7M
3
CYTK icon
Cytokinetics
CYTK
+$21.7M
4
AMGN icon
Amgen
AMGN
+$17.5M
5
CI icon
Cigna
CI
+$17.2M

Sector Composition

Rank Sector Weight
1 Healthcare 94.31%
2 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LH icon
26
Labcorp
LH
$26.1B
$11.4M 1.55%
+50,000
New +$10.5M
INSM icon
27
Insmed
INSM
$29B
$10.8M 1.48%
+350,000
New +$9.08M
UHS icon
28
Universal Health Services
UHS
$9.94B
$10.7M 1.45%
+70,000
New +$9.42M
KRYS icon
29
Krystal Biotech
KRYS
$9.68B
$10.5M 1.44%
85,000
+15,000
+21% +$1.66M
PEN icon
30
Penumbra
PEN
$12.9B
$10.1M 1.37%
+40,000
New +$8.84M
ICLR icon
31
Icon
ICLR
$12.8B
$9.91M 1.35%
+35,000
New +$9.06M
RGEN icon
32
Repligen
RGEN
$9.3B
$9.89M 1.35%
+55,000
New +$8.56M
MDT icon
33
Medtronic
MDT
$116B
$9.89M 1.35%
120,000
-180,000
-60% -$13.7M
CNC icon
34
Centene
CNC
$32.1B
$9.65M 1.31%
+130,000
New +$9.38M
ELV icon
35
Elevance Health
ELV
$84.7B
$9.43M 1.28%
20,000
-5,000
-20% -$2.31M
VKTX icon
36
Viking Therapeutics
VKTX
$3.94B
$9.3M 1.27%
500,000
-300,000
-38% -$3.92M
ACLX
37
DELISTED
Arcellx
ACLX
$8.88M 1.21%
+160,000
New +$7.22M
ALNY icon
38
Alnylam Pharmaceuticals
ALNY
$29.6B
$8.61M 1.17%
+45,000
New +$7.67M
CYTK icon
39
PUT
Cytokinetics
CYTK
$10.6B
$8.35M 1.14%
+100,000
New +$3.62M
EVH icon
40
Evolent Health
EVH
$464M
$8.26M 1.12%
+250,000
New +$7.07M
ALGN icon
41
Align Technology
ALGN
$12.3B
$8.22M 1.12%
+30,000
New +$7.11M
FDMT icon
42
4D Molecular Therapeutics
FDMT
$600M
$7.6M 1.03%
+375,000
New +$4.93M
ELAN icon
43
Elanco Animal Health
ELAN
$11.4B
$7.45M 1.01%
500,000
-248,000
-33% -$2.81M
BRKR icon
44
Bruker
BRKR
$8.69B
$7.35M 1%
+100,000
New +$6.41M
ARVN icon
45
Arvinas
ARVN
$588M
$7.2M 0.98%
+175,000
New +$4.09M
HOLX
46
DELISTED
Hologic
HOLX
$7.14M 0.97%
100,000
-25,000
-20% -$1.74M
CRNX icon
47
Crinetics Pharmaceuticals
CRNX
$8.95B
$7.12M 0.97%
200,000
– –
ILMN icon
48
Illumina
ILMN
$29.1B
$6.96M 0.95%
+51,400
New +$5.93M
ALKS icon
49
Alkermes
ALKS
$8.26B
$6.91M 0.94%
249,000
-26,000
-9% -$675K
SIBN icon
50
SI-BONE Inc
SIBN
$843M
$6.61M 0.9%
315,000
-170,000
-35% -$3.15M
1
2
3 4

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

Integral Health Asset Management's Q4 2023 Portfolio in Review

As of Q4 2023, Integral Health Asset Management held 98 positions worth $734M, up 1.7% from $722M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Integral Health Asset Management withdrew a net $87.4M in Q4 2023, closing 29 positions and reducing 20 holdings. Its most notable exit was argenx, an estimated $34.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, down from 97% a quarter earlier, followed by Consumer Discretionary.

Against the trend, Integral Health Asset Management opened a new position in AbbVie worth $26.3M.

  • Integral Health Asset Management's largest Q4 2023 buy was AbbVie: 170,000 shares worth $26.3M.
  • Integral Health Asset Management added most to Walgreens Boots Alliance in Q4 2023, an estimated $19M increase.
  • Integral Health Asset Management's biggest Q4 2023 reduction was Cytokinetics, cutting an estimated $21.7M.
  • Integral Health Asset Management fully exited argenx in Q4 2023, selling an estimated $34.4M.
  • Integral Health Asset Management's ten largest holdings make up 32% of its $734M portfolio in Q4 2023.
  • Integral Health Asset Management opened 33 new positions and closed 29 in Q4 2023.
  • Integral Health Asset Management's portfolio value rose 1.7% quarter-over-quarter to $734M.

Based on Integral Health Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.